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Abstract
Background: The prevalence of chronic diseases, such as immune, neurobehavioral, and metabolic disorders has
increased in recent decades. According to the concept of Developmental Origin of Health and Disease (DOHaD),
developmental factors associated with environmental exposures and maternal lifestyle choices may partly explain
the observed increase. Register-based epidemiology is a prime tool to investigate the effects of prenatal exposures
over the whole life course.
Our aim is to establish a Finnish register-based birth cohort, which can be used to investigate various
(prenatal) exposures and their effects during the whole life course with first analyses focusing on maternal
smoking and air pollution. In this paper we (i) review previous studies to identify knowledge gaps and
overlaps available for cross-validation, (ii) lay out the MATEX study plan for register linkages, and (iii) analyse
the study power of the baseline MATEX cohort for selected endpoints identified from the international
literature.
Methods/design: The MATEX cohort is a fully register-based cohort identified from the Finnish Medical Birth
Register (MBR) (1987–2015). Information from the MBR will be linked with other Finnish health registers and
the population register to link the cohort with air quality data. Epidemiological analyses will be conducted for
maternal smoking and air pollution and a range of health endpoints.
Discussion: The MATEX cohort consists of 1.75 million mother-child pairs with a maximum follow up time of
29 years. This makes the cohort big enough to reach sufficient statistical power to investigate rare outcomes,
such as birth anomalies, childhood cancers, and sudden infant death syndrome (SIDS). The linkage between
different registers allows for an extension of the scope of the cohort and a follow up from the prenatal
period to decades later in life.
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Background
The prenatal and early postnatal period is a time of
organ and tissue formation and functional programming,
making these periods highly susceptible for any kind of
insult. The concept of Developmental Origin of Health
and Disease (DOHaD) stresses the importance of pre-
natal exposures for diseases later in life [1]. According to
this concept, the increase in prevalence of chronic dis-
eases (e.g. respiratory diseases, cardiovascular diseases,
metabolic disorders) during the last decades is attributed
to developmental aberrations associated with environ-
mental exposures or imbalance in nutrition during preg-
nancy [2]. Although the DOHaD concept was originally
developed with a focus on nutrition during pregnancy, it
soon was applied also to toxicology and environmental
health [1]. The prenatal exposure to diethylstilbestrol
(DES), an artificial oestrogen and prescribed from 1940
to 1971 to millions of women during pregnancy to
reduce miscarriage, is one of the earliest cases where
prenatal exposure to a chemical was linked with serious
health effects later in life [1]. The focus on research
shifted from teratogenic effects, to effects of low-dose
exposures and epigenetic changes. These epigenetic
changes may explain the increase in chronic diseases,
such as allergies, asthma and metabolic disorders. Most
often effects of prenatal exposures are studied in animal
models. Epidemiological studies on the effects of pre-
natal exposures are very difficult, due to the long follow-
up time to catch chronic diseases which may manifest
tens of years after the exposures to etiological factors.
In addition to the sufficiently long follow-up, large
birth cohorts are essential to link prenatal exposures to
health effects later in life, because most effects are minor
or the endpoints rare, such as some birth anomalies or
childhood cancers. In order to be able to detect even
minor changes, which do not necessarily need to be
outside the “healthy” average range, big study sizes are
needed. Register based epidemiology allows to utilize
large study populations and to follow them even over
decades by linking various administrative registers, e.g.
on health, social welfare and population. Because pre-
natal development is the most sensitive period of life for
external insults (for reviews see e.g. [3, 4]), the possible
health effects of environmental risk facts are first observ-
able and most severe in maternally exposed offspring.
In our MATEX cohort we use the Finnish Medical
Birth Register (MBR) to define our study cohort. In
addition, by using the personal identification number,
introduced in 1964–1968 to all Finnish citizens and per-
manent residents, we link our cohort with the informa-
tion available in other health and population registers.
Health registers have a long tradition in Finland with the
earliest registers established in the 1950’s [5]. Finnish
registers are regularly used in research. Between 2010
and 2016 in total 962 authorisations for data use were
given by the National Institute for Health and Welfare
(THL), the main holder of health registers in Finland
during that period.
The MBR is frequently used in research for a wide
range of topics (see Additional file 1, Chapter 3. Exam-
ples of use of MBR data in published research). Most
commonly birth outcomes, such as birth weight, small
for gestational age and preterm birth are used from the
MBR. Other risk factors and health endpoints analysed
with MBR data, include for example socioeconomic
status [6, 7], maternal age [8, 9], reproductive history
[10], stillbirth and neonatal mortality [11, 12], and
neurodevelopmental disorders [13, 14]. The MBR data
are not always used for identification of the study popu-
lation or endpoints of interest, but also to identify
confounding factors [15]. The maternal smoking status
has been retrieved from the MBR in several studies
[16–19]. Although several studies analysed birth
cohorts from the MBR born between 1990 and 2010,
only one birth cohort from the MBR born after 2010
has been analysed, which aimed at the maternal age
at which risk for adverse pregnancy outcomes increases
[20], and only one study included children born before
1990, focusing on the effect of socioeconomic status on
the incidence of placental abruption [7]. No study investi-
gated the effects of exposure to air pollution or other
environmental risk factors during pregnancy on pregnancy
outcomes in a Finnish birth cohort.
Maternal smoking
Maternal smoking during pregnancy is the largest
preventable factor posing a risk to the health of the
mother and the child. The most severe complication
associated with prenatal tobacco smoke is sudden infant
death syndrome [21]. Additionally, smoking causes
premature birth, low birth weight, and being small for
gestational age, which all increase the risk for perinatal
mortality. Nicotine, the chemical causing the addictive
properties of tobacco, cause abnormal lung development
in utero, which has effects throughout the life of the
exposed child [22]. As a known teratogen, tobacco
smoke is associated with congenital anomalies [23].
Tobacco smoke contains hundreds of chemicals, some
of which are known carcinogens. In a meta-analysis it
was shown that smoking during pregnancy increases the
risk for brain and nervous system tumours in the child-
hood of the offspring [24]. Despite these well-established
consequences of maternal smoking, the fraction of preg-
nant women smoking remained stable at around 15% in
Finland from 1987 until today.
Since 1990 the smoking status of the mother is
recorded in the Finnish MBR during the 1st trimester
and at the end of the pregnancy, providing an excellent
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basis for a birth cohort focusing on the effects of mater-
nal smoking. From 1987 to 1990 the smoking status was
collected as non-smoker and below/above 10 cigarettes
per day. Only a limited number of studies [8, 17, 25]
have used the MBR for the analyses of the effects of ma-
ternal smoking during pregnancy on the infant (Fig. 1).
These studies did not include children born after 2010
and the analyses mostly focused on low birth weight,
premature birth and small for gestational age. Only one
study [17] analysed major congenital malformations as
part of their study. There is a clear knowledge gap in the
contribution of maternal smoking to specific congenital
malformations, childhood cancer and other morbidities
in mother and child.
Prenatal exposure to air pollution
The possible linkage of Finnish registers has great poten-
tial to be used in the future for the investigation of the
effects of prenatal ambient air pollution on the health of
infants and later in life. Ambient particulate matter
(PM) pollution is by far the most significant environ-
mental risk factor for disease and mortality both in
Finland and globally. Although health effects of exposure
to PM have been thoroughly studied in the adult and
elderly population, the effects of prenatal exposures are
not as well established. The exposure to PM2.5 has been
associated with for example low birth weight in full term
babies [26], preterm birth [27] and congenital abnormal-
ities [28]. Only a limited number of studies analysed the
effects of low concentration ambient PM (<10 μg/m3)
[27]. The ambient PM concentration in Finland is well
below the annual WHO limit of 10 mg/m3 for PM2.5.
The population weighted 3-year mean (2011–2013)
based on nine (sub)urban monitoring stations was
6.6 μg/m3 of PM2.5 [29]. There is a knowledge gap of the
impact of prenatal exposure to low level ambient air
pollution, especially for health endpoints other than low
birth weight and premature birth. The Finnish MBR has
not yet been used to study the effects of low level air
pollution exposure during pregnancy on pregnancy out-
comes and the health of the offspring later in life.
Study design and methods
Aims/objectives
The overall objectives of the MATEX project is the
development of a framework to link a birth cohort
identified from the Finnish Medical Birth Register with
information from other (health) registers for analyses of
prenatal exposures and their related health outcomes
over the whole life course. The register-based design will
allow for lifelong follow-up for the identification of
critical exposure time windows and health effects, which
become only apparent in later adulthood.
In the initial proof-of-concept analyses we will look at
the effects of prenatal exposure to maternal smoking
and probably to some extent to air pollution on
pregnancy outcomes, congenital anomalies, childhood
cancer, and childhood asthma. In this paper we (i) con-
duct a review of previous studies to identify knowledge
gaps and overlaps available for cross-validation, (ii) lay
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Fig. 1 Health endpoints available in the Medical Birth Register. Annual availability of health endpoints potentially useful for the analyses of the
effects of maternal smoking and air pollution. White space means that the data are not available for the year and grey marking means that the
data have been analysed previously for the effects of maternal smoking
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out the MATEX study plan for register linkages, and (iii)
analyse the study power of the baseline MATEX cohort
for selected endpoints identified from the international
literature.
The MATEX birth cohort
The MATEX birth cohort is identified from the Finnish
Medical Birth Register (MBR) [30]. The baseline
MATEX birth cohort consists of all births recorded in
the MBR between 1st January 1987 and 31st December
2015. The MATEX cohort includes personal information
of the mother, such as occupation, citizenship, marital
status and municipality of residence. Additionally, infor-
mation on past reproductive history is available: number
of previous ectopic pregnancies, miscarriages induced
abortions and whether she had a Caesarean section be-
fore. The main birth outcomes are recorded: gestational
age at birth, birth weight, birth length, head circumfer-
ence, 1 and 5 min Apgar score, sex of the child and
whether the child is born alive or dead. In addition, diag-
noses are available as ICD codes (1987–1995 as ICD-9
and 1996–2015 as ICD-10), as well as information on
risk factors, such as smoking and gestational diabetes or
hypertension, related to pregnancy and medical treat-
ments, e.g. drugs during pregnancy. The risk factors and
treatments, which are not recorded as ICD codes are
recorded as binary variable (yes/no). The sub-dataset
about delivery characteristics includes only binary and
categorical information for confounding analyses.
Amongst other, it includes the place of birth (hospital,
on the way to hospital, home), the mode of delivery,
induction of labour, and procedures associated with
delivery. Some of the variables have been introduced to
the MBR between 1990 and 2004. See Additional file 1
for a detailed overview of the available variables (see 161
Additional file 1, Chapter 1. Data availability in the Med-
ical Birth Register).
The MATEX baseline cohort encompassed 1,745,980
children born in a 29 year period (1987–2015), resulting
in about 27.5 million person-years. The average annual
number of births during that period was around 60,000
children. The average birth rate in the Finnish popula-
tion was 1.2%. The majority of mothers in the MATEX
cohort were Finnish, multiparous, and married or in a
registered partnership. The average maternal age was
29 years (25th–75th percentile: 26–33 years). Children
were on average born at 39 + 5 weeks + days gestation
with a birth weight of 3.5 kg and a head circumference
of 35 cm. The majority if children had an Apgar score of
9 or 10 at 5 min. Almost all deliveries were in hospital
with a majority being a spontaneous vaginal birth
(Table 1). For 1.2 million mothers the socioeconomic
classification based on occupation is available. Around
one third (34%) of all mothers was lower level employees
Table 1 Characteristics of mother-child pairs of the MATEX cohort
Characteristic Available
years*
n (%) or mean
(25th–75th percentile)
Mother
Age [years] 29 (26–33)
Pre-pregnancy weight [kg] 2004–2015 67 (57–73)
Height [cm] 2004–2015) 166 (161–170)
Primiparous 711,208 (41%)
Citizenship 1990–2015
Other than Finnish 64,730 (5%)
Self-reported smoking 1990–2015
No 1,436,322 (84%)
Quitted during 1st trimester 68,344 (4%)
Continued during 1st trimester 198,125(11%)
Marital status
Married/registered partnership
or cohabiting
1,112,771 (67%)
New-born
Sex (Female) 853,401 (49%)
Gestational age [week + days] 39 + 5
(39 + 0–40 + 6)
Birth weight [kg] 3.5 (3.2–3.9)
Head circumference [cm] 2004–2015 35 (34–36)
Apgar score at 5 min 1987–1989,
2004–2015
0–6 17,768 (2%)
7–8 72,137 (10%)
9–10 666,492 (88%)
Stillborn 6638 (0.4%)
Infant mortality (0–364 days of
age; excluding stillbirths)
6410 (0.4%)
Number of foetuses
Singletons 1,696,181 (97%)
Multiples 49,797 (3%)
Delivery
Place of birth 1990–2015
On the way to hospital 1225 (0.1%)
Outside hospital (planned) 332 (0.02%)
Outside hospital (unplanned/
no information)
1126 (0.1%)
Mode of delivery
Vaginal 1,336,572 (77%)
Breech, vaginal birth 10,186 (1%)
Vacuum 110,361 (6%)
Planned caesarean section 110,014 (6%)
Urgent/Emergency caesarean
section
174,810 (10%)
*Given if information is not available for the whole period (1987–2015)
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with administrative and clerical occupations. Together
less than a third of the mothers are either upper level
employees with administrative, managerial, professional
and related occupations (14%) or manual worker (14%).
The remaining mothers are students (8%), self-employed
(2%) or pensioners and un-employed (1%).
A general overview of the health status of the
mother-child pairs are shown in the supplement in
the form of incidence of chosen diseases occurring in
the perinatal phase as well as congenital anomalies
(see Additional file 1: Chapter 3).
Design of register linkages
The baseline MATEX cohort from the MBR will be
supplemented with data from other health registers, as
well as an exposure database, consisting of registers for
exposure linkage such as the Population Register (Fig. 2,
Table 2). All data will be pooled for analyses of exposure
response relationships.
The linkage of various registers via the personal identi-
fication number (PIN) of the child enables the follow-up
of the health history of the children after birth. Linkage
with the Register of Congenital Malformations [31] and
the Cancer Register [32] helps to identify all children of
the baseline cohort, who were born with congenital
anomalies, birth defects or who develop cancer later in
life. The Care Register for Health Care (HILMO) [33],
the Register of Primary Health Care Visits (AvoHILMO)
[34] (nationwide coverage since 2011), and the Register
of Reimbursement for Prescription Medicines [35]
allows to identify cases of specific disorders or diseases
later in life, for example asthma. The Cause-of-Death
Register facilitates the possibility to study mortality
associated with prenatal exposures [36]. Possible linkage
with the Population Register [37] can provide the home
address history of each mother-child pair, which will be
used to link the cohort with air quality data for the
investigation of effects of prenatal exposure to air
pollution. The register-based design potentially allows
for lifelong follow-up for the identification of critical ex-
posure time windows and health effects, which become
only apparent in later adulthood.
Different health registers can be used to follow the
health status of the children throughout life (Fig. 3). The
MBR is the main information source for the health of
mother and child during pregnancy and up to the first
week of life. In cases of induced abortion, no informa-
tion is available in the MBR, but under the women’s PIN
in the Register for Induced Abortions [38]. Induced
abortions for social reasons are legally allowed until
gestational week 20 and for medical reasons until
gestational week 24. All live births and stillbirth from
week 22 or with a minimum foetal weight of 500 g are
recorded in the MBR, no matter if the foetus is stillborn
or alive. Pregnancy-terminations at weeks 22–24 weeks
are not to be reported to the MBR. Pregnancy loss
before this milestone is legally considered to be a spon-
taneous abortion and the event is recorded under the
women’s PIN in HILMO/AvoHilmo. A live born child
receives his/her PIN at birth.
Fig. 2 Schematic description of the planned register linkage of the MATEX cohort. The Matex cohort is recruited from the MBR with other
registers for the two proof-of-concept case studies. Registers are linked via mother’s personal identification number (PIN) (for the Population
Register) or the child’s PIN (all other registers). The main exposures targeted will be maternal smoking and air pollution. The main endpoints will
be birth outcomes, childhood asthma, childhood cancer and congenital anomalies
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Statistical power of the MATEX cohort
The statistical power of the MATEX cohort was estimated
using R software epiR package. The smallest detectable
relative risk (RR) was computed for an analyses using 95%
confidence interval and a study power of 90%. The smal-
lest detectable RR was calculated for a range of incidence
rates and exposure rates for the total MATEX cohort, as
well as the part of the cohort, born 2004 or later, when the
latest variables were introduced to the MBR. Additionally,
the smallest detectable RR was compared with published
RR for outcomes associated with maternal smoking.
For incidence rates between 0.1% to 50% the MATEX
cohort has reasonable power (Fig. 4) to detect outcomes
associated with a wide range of exposures (exposure
prevalence 1% to 30%). The total MATEX cohort has
90% power to detect outcomes with an incidence rate of
0.1% and a RR ≤ 1.5 for exposure prevalent in 10% or
more of the MATEX cohort.
Table 2 The Finnish registers and their data content used in the MATEX project
Register Data available Register holder Ref.
Medical Birth Register Mother’s health data (incl. Smoking habits prior to and
during pregnancy, other risk factors, interventions),
pregnancy, delivery, live and stillbirths, GD, BMI, infant
health data by age of 7 days
THL [30]
Register of Induced Abortions Data on mother, indication for induced abortion,
diagnoses
THL [38]
Register of Congenital Malformations Mother’s health data, pregnancy, foetus/child,
congenital anomalies and birth defects, diagnoses
(ICD codes)
THL [31]
Care Register for Health Care Data from hospitals and special health care, diagnoses THL [33]
Register of Primary Health Care Visits Data outpatient health care visits, diagnoses
(available since 2011)
THL [34]
Cancer Register Persons with cancer, data on cancer type and death
certificate
THL [32]
Cause-of-Death Register Causes of death, death certificates Statistics Finland [36]
Register of reimbursements for
Prescription Medicines
Purchases of prescription medication eligible for
reimbursement
KELAa [35]
Finnish Maternity Cohort Serum bank, data on mother, sampling date,
expected due date, previous pregnancies
THLb [42]
Population Register Address history Population
Register Center
[37]
aFinnish Social Security Institution; bFrom June 2017 the samples will be transferred to the Biobank Borealis of Northern Finland, established and maintained by
the Northern Ostrobothnia Hospital District, the University of Oulu, NordLab and the hospital/healthcare districts of Lapland, Länsi-Pohja, Central Ostrobothnia
and Kainuu
Fig. 3 Possibility for life-long follow-up of the health status of the birth cohort by utilizing registers. The cohort can be followed using the personal
identification number (PIN) of the child, except of the case of induced abortion (recorded under mother’s PIN). In the case of spontaneous abortion
the record is partly available from the woman’s health register. Emigration outside of Finland causes the loss for follow up of the child
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When planning the MATEX cohort, health endpoints
associated with maternal smoking (birth outcomes, con-
genital anomalies, childhood cancer) have been selected
based on a literature review and the needed cohort size
was estimated [39]. After receiving the data, the chance
to detect the reported RRs in the MATEX cohort, has
been re-calculated (Fig. 5). Despite the large study popu-
lation, it seems unlikely that the cohort has sufficient
power to result in statistically significant risk estimates
for most congenital anomalies and childhood cancers.
The cohort has enough statistical power that statistically
significant risk estimates can be expected for the main
birth outcomes.
Planned analyses
Exposures
Information on maternal smoking is retrieved from
the MBR. The information is collected by the midwife
during the antenatal visits. Maternal smoking status is
available as four categories: (i) non-smoker, (ii) quitted
smoking during first trimester, (iii) continued smoking
after the first trimester, or (iv) no information. A prelimin-
ary analysis of the smoking status in the MATEX birth
cohort suggests that about 15% of all children are exposed
to maternal smoking at some point of the pregnancy with-
out any trend during the study period (1987 to 2015).
However, the fraction of women quitting smoking during
the first trimester is increasing during the last decades.
Additionally, smoking prevalence is higher in mothers
younger than 20 years compared to mothers older than
30 years. In a study comparing the MBR smoking infor-
mation with serum samples analysed for cotinine, the
non-disclosure rate of smoking was reported to be 8% and
the rate of inactive smoking mothers was reported to be
5% [40].
Air pollution exposure can be linked with the
mother-child pairs via the home address of the
mother during pregnancy. Modelled ambient concen-
trations data will be available for PM with a diameter
of less than 2.5 μm (PM2.5) and less than 10 μm
(PM10), as well as 30 gaseous components of air pol-
lution. The gaseous components include amongst
others carbon dioxide (CO2), carbon monoxide (CO),
ozone (O3), nitrogen dioxide (NO2) and sulphur diox-
ide (SO2). The effect of exposure during the whole
pregnancy, the three trimesters separately, and the
last week of pregnancy can potentially be analysed.
The analyses can be widened by the inclusion of other
exposures. The occupational status of the mothers is
available as Classification of Occupation [41] and can be
analysed for occupation specific risks. It is well estab-
lished, that some occupations are characterised by spe-
cific exposures for examples farmers and pesticides, hair
dressers and chemicals, and painters and solvents. The
Finnish Maternity Cohort serum samples can be used to
assess the exposure to chemicals, such as perfluorinated
compounds and organochlorine pesticides [42].
Health outcomes
The health endpoints of interest have been selected a
priori based on a literature review of previous studies.
Four main categories of health endpoints will be included
in the analyses: (i) pregnancy outcomes, (ii) congenital
malformations, (iii) childhood cancer, and (iv) asthma.
As pregnancy endpoints mainly gestational age
(preterm birth), birth weight, size for gestational age
(small for gestational age, SGA), head circumference and
Apgar score will be analysed. The effects of maternal
smoking or air pollution on stillbirth and Sudden Infant
Death Syndrome (SIDS) will be analysed. Additional
analyses will potentially be done for respiratory prob-
lems in the infant (diagnoses, need for intubation) and
gestational illnesses in the mother (diabetes, hyperten-
sion, (pre-)eclampsia).
The effects of prenatal exposures on congenital anom-
alies will be analysed for all major malformations as a
group and specific malformations if the incidence rate
Fig. 4 Minimum detectable RR for risk factors (RR ≥1) for five
incidence rates. The minimum detectable relative risk (RR) has been
estimated for five incidence rates (0.1%, 1%, 5%, 10%, 25%) and a
range of an exposed fraction of the MATEX cohort between 1 and
30%. The red area describes RRs not detectable within reasonable
exposure prevalence and disease incidence, the yellow area
describes RRs possibly detectable depending on exposure
prevalence and/or disease incidence, and the green area describes
the RRs which can be detected in whole range of exposure
prevalence and disease incidence. A study power of 90% has
been assumed
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is high enough for sufficient study power. For mini-
mum estimates if the incidence rates, see Additional file 1:
Table S2. Congenital malformation analyses will include
physical anomalies as well as chromosomal and genetic
anomalies. Down syndrome is of particular interest as a
chromosomal anomaly.
Childhood cancer will be included as an endpoint in
the analyses if sufficient study power can be reached.
Leukaemia is most promising in terms of study power,
because it is the most common cancer in childhood.
However, the evidence for an association with maternal
smoking is limited [24]. The evidence for an association
of maternal smoking with brain cancer is stronger, but
the incidence rate is lower, limiting the statistical power
of the MATEX cohort. It is not expected that enough
specific cancer cases are recorded during the study
period to confidently expect sufficient study power.
Asthma can be interpreted as a continuum of
respiratory problems after birth. Potentially asthma
can be defined based on the entitlement for medical
reimbursement for asthma medication. Additionally,
data are available for diagnoses made in in- or out-
patient care from the Care Register of Health Care
and the Register of Primary Health Care Visits.
Confounding analyses
Due to the full register-based design of the MATEX
study, only information recorded in the (health)
a
b
c
Fig. 5 Example for the study power of the MATEX cohort and maternal smoking as exposure. The smallest detectable RR in the MATEX cohort in
(study power = 90%) is compared with RR, which have been reported for birth outcomes (Panel a), congenital anomalies (Panel b) and childhood
cancer (Panel c) [23, 57]
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register can be used for adjustment for confounding
factors. In general, the assumption is that the risk for ad-
verse pregnancy outcomes increases with a maternal age
of 35 years. However, for the Finnish population it was
reported, that the risk for some pregnancy outcomes in-
creases significantly already in earlier age [20]. This under-
lines the importance of maternal age as a confounding
factor as a continuous variable, and not as a binary
variable of younger or older than 35 years.
Socio-economic status is a strong confounding
factor. We will use the Finnish Classification of
Socioeconomic Groups based on the occupation of
the mother recorded in the MBR. The classification is
based on eight main socioeconomic groups and was
developed in 1989 [43]. The information is available
in the MBR since 1990. Socioeconomic status is a
strong indicator of health behaviour and dietary
habits. Several studies showed that the risk for ad-
verse pregnancy outcomes differs between socioeco-
nomic groups in Finland [6, 7, 25].
Maternal smoking, gestational age, birth weight and
diseases during pregnancy are available from the MBR
and will be used as confounding factors as appropri-
ate. Gestational age and (not well managed) maternal
diabetes heavily affect birth weight. The child’s sex,
the mother’s citizenship and birth order are available
from the MBR for confounding analyses.
The effect of the physical location on the exposure-
response relationship can potentially be investigated
based on the municipality of residence of the mother
during pregnancy. It can be used to assign the degree
of urbanisation in the municipality of residence of the
mother.
The Finnish health care system divides hospitals
into three levels, based on the level of specialised
treatment that is offered. Birth in smaller hospitals
and less specialised hospitals (level 2 compared to
level 3) has been shown to increase the risk for neo-
natal mortality [11, 12]. Information on the hospital
and where each birth in the cohort was given is avail-
able and can be used to adjust for the confounding
effect of hospital type.
The register-based design limits the ability to adjust
for those confounding factors, which are not recorded
in the registers. Paternal smoking, for example, is not
recorded in any register and therefore cannot be in-
cluded in any of the analyses. Information on other
lifestyle factors (physical activity, diet, alcohol con-
sumption) is not available either. Additionally, some
factors, which are important for confounding analyses,
such as maternal height and weight, have been intro-
duced to the MBR only in 2004. These limitations
need to be taken into account when planning for the
various analyses.
Statistical models and possibilities for various analyses
Due to the various analyses that will be conducted, a de-
tailed description of each of the analyses is not possible
within the scope of this paper. However, mainly bi-
variable analyses will be performed to evaluate statis-
tical differences in variables between exposure groups
using the χ2 test. For continuous variables – as
applicable - independent sample t test will be used.
Multivariable logistic regression analysis will be
performed to calculate RRs or ORs with 95% CIs
between exposure and each adverse perinatal out-
come. Depending on the outcome, different statistical
methods need to be used. Each analysis will be
adjusted to confounding factors as appropriate. The
statistical analyses will be done in R statistical software.
The rich dataset allows for analyses of continuous vari-
ables (birth weight, gestational age, head circumference)
either as a continuous variable or as a categorical vari-
able based on international disease definitions, such as
(very) low birth weight and (very) preterm birth. The
other variables can only be analysed as categorical or
binary variables.
To some extent critical windows of exposure can be
investigated. The effects of maternal smoking
throughout the whole pregnancy can be compared to
the effects of smoking only during the first trimester.
The effects of prenatal air pollution can be analysed
for average concentration or peak concentration, as
well as during different periods of the pregnancy.
In order to estimate the disease burden associated
with maternal smoking and air pollution, the
Burden of Disease (BoD) will be estimated according
to the WHO method [44]. The quantification of the
health impact will provide valuable estimates about
the magnitude of the health impact, as well as the
severity of health endpoint in terms of healthy life
lost.
Discussion
Register-based birth cohorts provide ultimately possi-
bilities to study the effects of prenatal and childhood
exposures throughout the life course and to identify
sensitive or critical time windows as is already clear
from the studies carried out using the Finnish Birth
Register [17, 19, 20]. In the current work our special
focus is on the early postnatal period with the
lifelong follow-up remaining as a readily available
option. The linkage of multiple health registers
supports comprehensive case identification and
follow up. The current baseline cohort size of 1.75
million children leads to high study power, which is
sufficient to study even rare endpoints, such as birth
malformations and childhood cancer.
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Scientific knowledge gaps and potential of the MATEX
birth cohort
Maternal smoking is an established cause for low
birth weight and preterm birth [21]. Nevertheless,
there is controversy about the association between
maternal smoking and childhood cancers or specific
congenital anomalies. These outcomes have low inci-
dence rates requiring big studies to reach sufficient
study power. Case-control design is often applied to
identify most cases without the need for the big size
of a cohort study [45]. Case-control design is retro-
spective leading potentially to recall bias of exposures
during the pregnancy, which may have occurred
decades earlier. Additionally, both case-control and
cohort designs may be biased in the recruitment of
the controls or study population. Register-based ap-
proach minimises the potential for both biases [5].
The health registers cover virtually the whole popula-
tion. Therefore there is no risk that some population
groups are over- or under-represented. The use of
exposure databases minimises the risk for recall bias.
The fully register-based design limited to the available
data, which, in the case of the Finnish Birth Register,
have been collected for use over the 29 year recruitment
period. It is should be noted that some important
confounding variables are missing for certain years, such
as maternal height and weight, as well as the socioeco-
nomic group. Additionally, some possibly important
confounding factors are not available, for example pater-
nal smoking, alcohol consumption during pregnancy
and physical activity. Furthermore, nicotine replacement
therapy is potentially important, in the light of the feto-
toxicity of nicotine found in animal studies (for a recent
review, see [46]). However, it has been used only for a
short period and the data has not been systematically
collected in the birth register. Overall, except of mater-
nal smoking, no lifestyle information is available. Due to
the large cohort size, it is not feasible to collect
additional data via questionnaires or interviews. For
variables that are temporarily restricted, the cohort can
be analysed in two groups (one with adjustment for the
variable, one without the adjustment) to investigate the
magnitude of the confounding.
Harmful effects of prenatal exposure to cigarette
smoke on the 2nd generation include implications of
e.g. germ cell mutations in the case of maternal
smoking during pregnancy or paternal preconcep-
tional smoking [47], but are not well-established,
while the effects of air pollution have not been stud-
ied at all. The MATEX cohort is recruited over a
long enough time that we can identify potential
pregnancies of women, who are included in the
cohort at birth. The oldest members of the cohort are
currently 29 years old and the mean maternal age at
pregnancy is 29 years. Later on the current focus on ma-
ternal smoking and air pollution may be widened to other
prenatal exposures. The Finnish Maternity Cohort, that
contains first trimester serum samples from 2 million
pregnant women since 1983 (national coverage 95% of all
pregnancies), as well as other Finnish blood and serum
banks can be used for exposure assessment to chemicals
[42]. The availability of address history has the potential
to investigate exposures emitted from stationary sources,
such as (nuclear) power plants, industrially contaminated
sites, high voltage power lines or transformer stations
(extremely low magnetic fields).
Nordic health registers are to a great extent similar,
which opens the possibility for Nordic collaboration to
increase the cohort size even further [48]. This would
increase the study power in order to investigate rare
outcomes associated with low prevalence exposures,
such as illegal drugs.
Register-based epidemiology is restricted to data,
which are routinely collected in registers. Most registers,
however, have not been designed for research purposes
per se, but rather for statistical purposes. Hence, some
information important and interesting for research is
missing. Information on lifestyle is not available, except
of maternal smoking in the MBR. No data about pater-
nal smoking or the use of nicotine products, such as
chewing gums and skin patches, are available. Addition-
ally, data on alcohol consumption, physical activity, eat-
ing habits and other exposures are missing. The data
availability limits the possibility to adjust for confounders.
Ethical and legal considerations
The routine collection of data for health register means
more work for the health professionals, who collect the
data, as well as costs to collect the data and maintain the
register. These costs are paid by public funding. Utilizing
data that is collected and stored anyway is cost-efficient.
There is an ethical duty of the society to use the available
data to improve public health and the health services.
Utilization of the data not only for statistics, but also
research, justifies the increased work load and costs to
maintain the register. Because individuals barely have a
chance to voice their opinion whether they want their data
to be collected or to be used in research, the research
community should do its best to make use of the data in a
responsible way, not only for science, but especially to
improve public and health services for the individuals.
Additionally, the scientific community has the ethical
responsibility to disseminate the results and conclusions
both within the scientific community, and to the general
public (e.g. [49]. This means that the results should not
only be published in scientific journals, but also in general
newspapers and responsible social media in plain lan-
guage, ensuring that the public benefits, too.
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Finnish and European legislation (Act on the Open-
ness of Government Activities (621/1999) [50]; Section
8.4, Personal Data Act (523/1999) [51]; European level
Directive 2016/679 (accepted 27th April 2016, to be
implemented by 25 May 2018) [52] regulate the use of
personal data for various purposes including research.
Generally (Declaration of Helsinki [53]), and according
to Finnish law (488/1999) [54] research must be based
on the consent of research subjects, unless obtaining
consent is unduly difficult and the research cannot be
carried out without using the data. In this case the
prerequisites set out in the law must be satisfied for an
exception from the need for informed consent. The full
register-based study design qualifies for such an exemp-
tion from the need for informed consent. Besides, the
majority of Finnish public considers the benefit for
public health more important than the individual right
to privacy [55]. However, in the study by Eloranta and
Auvinen [55], information about ongoing and new
register-based research was deemed inadequate and
register-based research was in general seen as an un-
familiar topic. In the MATEX study only coded informa-
tion without PINs and names are being used, disabling
the direct identification of individuals. Additionally, the
statistical analyses do not require us to work with data
of individuals, but only with the data as a set. The publi-
cation plan includes this study protocol, giving the possi-
bility to inform the society how their data will be used.
Additionally, the results of the analyses will not only be
published in scientific articles, but also in newspaper
articles aimed at the general public.
Data protection is crucial when health data are
used, because of the importance to protect privacy
and inhibit misuse of the data (e.g. [49, 56]). Individ-
uals may be identified based on their characteristics
and health history, even with unidentified data. In
human biomedical studies a positive statement from
an ethics committee is required by law in Finland
(488/1999) before filing the request to the register
holder for obtaining data. Among the crucial aspects
are that data protection is sufficient and that a plan
exists, what will be done with the data once the study
is finished [5]. For register-based studies, no ethics
committee statement is required in Finland.
Conclusions
Register study designs provide a cost efficient oppor-
tunity to study public health impacts of environmen-
tal risk factors. In this work we establish a baseline
birth cohort and demonstrate its functionality and
evaluate it by studying the effects of maternal smok-
ing. The big study size allows observations of small
risks associated with common exposures. In addition, it
potentially allows the inclusion of rare outcomes and rare
exposures. The register-based design makes follow-up and
extension of the cohort easy and straight forward. Thus,
health effects of foetal exposure over the whole life course
can be studied. Exposure data can be linked via home ad-
dress, serum banks or additionally collected information
of the mother-child pairs.
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